[Estimation of the relative cancer risk in the upper aerodigestive tract using malignancy-associated biomarkers].
Bloching
M B
MB
Klinik für HNO-Heilkunde, Kopf- und Halschirurgie der Martin-Luther-Universität. marc.bloching@medizin.uni-halle.de
D014408:Biomarkers, Tumor / Q000235:genetics*; D016022:Case-Control Studies; D002455:Cell Division / Q000235:genetics / Q000502:physiology; D019938:Cyclin D1 / Q000235:genetics; D015972:Gene Expression Regulation, Neoplastic / Q000502:physiology; D006801:Humans; D019394:Ki-67 Antigen / Q000235:genetics; D007972:Leukoplakia, Oral / Q000175:diagnosis* / Q000235:genetics; D008403:Mass Screening; D015162:Micronucleus Tests; D009061:Mouth Mucosa / Q000473:pathology; D009152:Mutagenicity Tests; D010039:Otorhinolaryngologic Neoplasms / Q000175:diagnosis* / Q000235:genetics; D011237:Predictive Value of Tests; D018809:Proliferating Cell Nuclear Antigen / Q000235:genetics; D012016:Reference Values; D018570:Risk Assessment; D012463:Saliva / Q000378:metabolism; D016159:Tumor Suppressor Protein p53 / Q000235:genetics
D014408:Biomarkers, Tumor; D019394:Ki-67 Antigen; D018809:Proliferating Cell Nuclear Antigen; D016159:Tumor Suppressor Protein p53; D019938:Cyclin D1